We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Could Persistent CD30 Signaling Lead to Blood Cancers?

News   Apr 15, 2019 | Original story from Helmholtz Zentrum München

 
Could Persistent CD30 Signaling Lead to Blood Cancers?

Credit: Pixabay

 
 
 

RELATED ARTICLES

Biodegradable Nerve Guide Helps Regenerate Damaged Nerves

News

Scientists have created a biodegradable nerve guide consisting of a polymer tube filled with a growth-promoting protein, glial cell-derived neurotrophic factor, or GDNF. The results in nonhuman primate studies are promising.

READ MORE

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Long-hidden Metabolic System Unlocks Cancer Secrets

News

Researchers have identified a long-hidden metabolic system in cells, which could provide a new opportunity to find ways to suppress cell proliferation in cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE